Merck's pill, which would be the first to treat COVID-19, is administered orally in capsule form every 12 hours for five days.
The global tally of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 238 million on Monday, as Merck submitted an application to the U.S. Food and Drug Administration for emergency authorization of what would be the first pill-based treatment for the deadly illness.
The U.K. pharmaceutical company said the trial met its primary endpoint, and that AZD7442 was the only long-acting antibody combination shown to both prevent and treat COVID. Fauci told CNN’s “State of the Union” on Sunday that it’s an important time of year for children, and that they can “go out there” and “enjoy it.”
But the daily death toll has crept back up to an average of 2,000, the tracker shows, after coming down to about 1,800 a day last week. As most cases, hospitalizations and deaths are in unvaccinated people, health experts continue to push those people to get their shots and avoid dying a preventable death.
Elsewhere, Russia suffered 957 new COVID deaths on Monday, the Moscow Times reported, but to protect the economy the Kremlin is rejecting new public health restrictions. Russia has one of the lowest vaccination rates in Europe at just over 30%. “I see it as a day of freedom, it’s a freedom day,” New South Wales Premier Dominic Perrottet told reporters in Sydney, the capital of that state. “We are leading the nation out of this pandemic but this will be a challenge.”
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Covid-19: NHS Covid passes, and lockdown lifted in SydneyFive things you need to know about the coronavirus pandemic this Monday morning.
Baca lebih lajut »
Covid-19: Three more Covid-related deaths and 1,115 new casesThe total number of coronavirus-linked deaths in NI since the start of the pandemic is 2,588.
Baca lebih lajut »
Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravirMerck said it is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.
Baca lebih lajut »
Merck asks the FDA to authorize use of its promising COVID-19 pillDrugmaker Merck has asked U.S. regulators to authorize its promising pill protecting against COVID-19, setting the stage for a decision within weeks.
Baca lebih lajut »